Puration Inc (PURA)

[BottomTurn]

Last Signal: BUY
Last Pattern: BULLISH DOJI STAR

?

KALY Potential PPS Run From $0.01 to $0.04 On Way To $0.10

The KALY PPS experienced a dramatic dip on Monday following Friday’s FDA non-committal comments on CBD and then rebounded on high volume on Tuesday.  Now KALY has a buy recommendation and is still below the almost $0.04 high it reached late last year after acquiring the US Patented Cannabis Extraction Process that is currently the center of the company’s growing value.  With KALY’s patented cannabis pharmaceutical research now coming to light, the PPS is positioned to shoot past the recent $0.04 highs to a level putting it on par with some of the other penny cannabis stock contenders.  A $0.10 PPS is not an unreasonable milestone after singing a $5 million CBD extraction contract.

KALY is providing CBD extracts for over $1 million worth of CBD infused water produced by Puration, Inc. (USOTC: PURA), and KALY has also introduced its own CBD infused gum, Hemp4mula available on North American Cannabis Holdings, Inc.’s website www.USMJ.com.  KALY is also implementing an extraction lab to process biomass from Nouveau’s (USOTC: NOUV) 100 acer hemp farm.

Following the acquisition of the patented cannabis extraction process late last year and the corresponding jump in price and trading volume, the OTC Markets flagged the company in response to the jump in activity.  The company has responded by updating all its OTC Markets required reports.  Management is likely to mitigate the OTC Market’s concerns sooner or later and see the flag removed which will likely be yet another impetus fueling a KALY PPS run.  

Management engaged Goldman Small Cap Research to conduct analyst coverage of the company and file an initial analyst report:  KALY Research Report